World's Best Scientists 2026 revealed!
Ekaterina S. Jordanova

Ekaterina S. Jordanova

D-Index & Metrics

Immunology

D-Index
66
Citations
12684
World Ranking
2797
National Ranking
105

Overview

Ekaterina S. Jordanova is affiliated with Vrije Universiteit Amsterdam in the Netherlands. Their research primarily focuses on the field of Medicine, with particular emphasis on Surgery, Epidemiology, Immunology, Oncology, and Obstetrics and Gynecology as subfields of study.

The scientist's major topics of research include:

  • Cervical Cancer and HPV Research
  • Genital Health and Disease
  • Colorectal and Anal Carcinomas
  • Cancer Immunotherapy and Biomarkers
  • Immunotherapy and Immune Responses
  • Immune Cell Function and Interaction
  • Endometrial and Cervical Cancer Treatments

Ekaterina S. Jordanova has contributed to several recent papers, including:

  • "PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker Potential" (2020) published in Frontiers in Immunology
  • "Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer" (2021) published in Clinical Cancer Research
  • "Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site" (2020) published in British Journal of Cancer
  • "Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial" (2023) published in Journal of Clinical Oncology
  • "Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy" (2022) published in Angiogenesis

The frequent coauthors collaborating with this scientist include:

  • Gemma G. Kenter
  • Tanja D. de Gruijl
  • Sanne Samuels
  • Henry Zijlmans
  • Roman Rouzier

Publications by Ekaterina S. Jordanova have appeared regularly in prominent venues such as:

  • Frontiers in Immunology
  • Clinical Cancer Research
  • British Journal of Cancer
  • Journal of Clinical Medicine
  • Cancer Research

Best Publications

  • Targetable genetic features of primary testicular and primary central nervous system lymphomas

    Bjoern Chapuy;Margaretha G. M. Roemer;Margaretha G. M. Roemer;Chip Stewart;Yuxiang Tan

  • High Number of Intraepithelial CD8+ Tumor-Infiltrating Lymphocytes Is Associated with the Absence of Lymph Node Metastases in Patients with Large Early-Stage Cervical Cancer

    Sytse J. Piersma;Ekaterina S. Jordanova;Mariëtte I.E. van Poelgeest;Kitty M.C. Kwappenberg

  • Tumor-Expressed B7-H1 and B7-DC in Relation to PD-1+ T-Cell Infiltration and Survival of Patients with Cervical Carcinoma

    Rezaul Karim;Ekaterina S. Jordanova;Sytse J. Piersma;Gemma G. Kenter

  • Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix.

    A. Marijne Heeren;Simone Punt;Maaike C. G. Bleeker;Katja N. Gaarenstroom

  • Human Leukocyte Antigen Class I, MHC Class I Chain-Related Molecule A, and CD8+/Regulatory T-Cell Ratio: Which Variable Determines Survival of Cervical Cancer Patients?

    Ekaterina S. Jordanova;Arko Gorter;Ouissam Ayachi;Frans Prins

  • Extensive genetic alterations of the HLA region, including homozygous deletions of HLA class II genes in B-cell lymphomas arising in immune-privileged sites.

    Sietske A. Riemersma;Ekaterina S. Jordanova;Roelandt F. J. Schop;Katja Philippo

  • Detection of M2-macrophages in uveal melanoma and relation with survival.

    Inge H G Bronkhorst;Long V Ly;Ekaterina S Jordanova;Johannes Vrolijk

  • Prognostic Significance of MYC Rearrangement and Translocation Partner in Diffuse Large B-Cell Lymphoma: A Study by the Lunenburg Lymphoma Biomarker Consortium.

    Andreas Rosenwald;Susanne Bens;Ranjana Advani;Sharon Barrans

  • HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes

    Marloes Jm Gooden;Margit H Lampen;Ekaterina S Jordanova;Ninke Leffers

  • Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.

    Akash M. Mehta;Ekaterina S. Jordanova;Gemma G. Kenter;Soldano Ferrone

  • Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma.

    Willem Maat;Long V. Ly;Ekaterina S. Jordanova;Didi de Wolff-Rouendaal

  • Blocking tumor-educated MSC paracrine activity halts osteosarcoma progression

    S. Rubina Baglio;Tonny Lagerweij;Maria Pérez-Lanzón;Xuan Dung Ho

  • Intratumoral HPV16-Specific T Cells Constitute a Type I-Oriented Tumor Microenvironment to Improve Survival in HPV16-Driven Oropharyngeal Cancer

    Marij J.P. Welters;Wenbo Ma;Saskia J.A.M. Santegoets;Renske Goedemans

  • Sensing of latent EBV infection through exosomal transfer of 5′pppRNA

    S. Rubina Baglio;Monique A. J. van Eijndhoven;Danijela Koppers-Lalic;Jordi Berenguer

  • Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma.

    Inge H G Bronkhorst;T H Khanh Vu;Ekaterina S Jordanova;Gregorius P M Luyten

  • Immunological profiling of molecularly classified high-risk endometrial cancers identifies POLE-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition.

    Florine A. a Eggink;Inge C. b Van Gool;Alexandra c Leary;Pamela M. d Pollock

  • Array-Based Comparative Genomic Hybridization Analysis Reveals Recurrent Chromosomal Alterations and Prognostic Parameters in Primary Cutaneous Large B-Cell Lymphoma

    Remco Dijkman;Cornelis P. Tensen;Ekaterina S. Jordanova;Jeroen Knijnenburg

  • Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma

    Marcel A. Deken;Jules Gadiot;Ekaterina S. Jordanova;Ruben Lacroix

  • Human Papillomavirus Prevalence in Invasive Penile Cancer and Association with Clinical Outcome

    Rosa S. Djajadiningrat;Ekaterina S. Jordanova;Bin K. Kroon;Erik van Werkhoven

  • Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors

    Minka van Dongen;Nigel D.L. Savage;Ekaterina S. Jordanova;Inge H. Briaire-de Bruijn

  • High and Interrelated Rates of PD-L1+CD14+ Antigen-Presenting Cells and Regulatory T Cells Mark the Microenvironment of Metastatic Lymph Nodes from Patients with Cervical Cancer

    A. Marijne Heeren;Bas D. Koster;Sanne Samuels;Debbie M. Ferns

Frequent Co-Authors

Gert Jan Fleuren
Gert Jan Fleuren Leiden University Medical Center
Gemma G. Kenter
Gemma G. Kenter Vrije Universiteit Amsterdam
Arko Gorter
Arko Gorter Leiden University Medical Center
Martine J. Jager
Martine J. Jager Leiden University Medical Center
Sjoerd H. van der Burg
Sjoerd H. van der Burg Leiden University Medical Center
Tanja D. de Gruijl
Tanja D. de Gruijl Vrije Universiteit Amsterdam
Marij J. P. Welters
Marij J. P. Welters Leiden University Medical Center
Simon Horenblas
Simon Horenblas Antoni van Leeuwenhoek Hospital
Ed Schuuring
Ed Schuuring University Medical Center Groningen
Tom van Wezel
Tom van Wezel Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, complementary healthcare degrees offer diverse career opportunities. Many start with programs like the best online BSN programs for non nurses, which provide foundational nursing knowledge alongside immunology-related concepts. These programs are designed to help non-nurses transition smoothly into the nursing field, broadening their scope of practice.

If you're seeking a quicker route, the easiest ABSN to get into can be a strategic choice. Accelerated Bachelor of Science in Nursing (ABSN) programs offer intensive study schedules that allow students to enter the healthcare workforce faster, often incorporating immunological studies relevant to patient care.

For those considering practical nursing, exploring which LPN programs are easiest to get into can provide pathways into clinical environments where immunology plays a critical role in patient management and infection control.

Finally, advancing to advanced practice roles like a Family Nurse Practitioner is another promising direction. The easiest FNP program options offer flexible paths to gain the expertise needed for specialized immunological care and leadership in healthcare settings.

Best Scientists Citing Ekaterina S. Jordanova

Trending Scientists